Clinical Trial Update: Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 clinical trial evaluated radiolabeled monoclonal antibody therapy in patients with leukemia or lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• Radiolabeled Monoclonal Antibody Therapy

Snippet

Sponsor: Garden State Cancer Center at the Center for Molecular Medicine and Immunology | Conditions: Leukemia, Lymphoma | Phase 1, Phase 2 | Status: COMPLETED